3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one

3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one Struktur
1053-21-0
CAS-Nr.
1053-21-0
Englisch Name:
3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one
Synonyma:
Buxenone;Buxenone M;Cyclobuxophyllinine;Cyclobuxophyllinine M;3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one;(17E)-4,4,14-Trimethyl-3β-(methylamino)-9,19-cyclo-5α-pregn-17(20)-en-16-one;(17E)-4,4,14-Trimethyl-3β-(methylamino)-9β,19-cyclo-5α-pregn-17(20)-en-16-one;9,19-Cyclopregn-17(20)-en-16-one, 4,4,14-trimethyl-3-(methylamino)-, (3β,5α,17E)-
CBNumber:
CB62190482
Summenformel:
C25H39NO
Molgewicht:
369.58
MOL-Datei:
1053-21-0.mol

3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one Eigenschaften

Schmelzpunkt:
174 °C
Siedepunkt:
474.9±45.0 °C(Predicted)
Dichte
1.06±0.1 g/cm3(Predicted)
pka
10.66±0.70(Predicted)

Sicherheit

3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one Chemische Eigenschaften,Einsatz,Produktion Methoden

3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
SIMAGCHEM CORP
+86-13806087780
sale@simagchem.com China 17367 58
Chembest Research Laboratories Limited +86-21-20908456
sales@BioChemBest.com China 6008 61

  • 3β-(Methylamino)-4,4,14-trimethyl-9,19-cyclo-5α-pregn-17(20)-en-16-one
  • Buxenone
  • (17E)-4,4,14-Trimethyl-3β-(methylamino)-9,19-cyclo-5α-pregn-17(20)-en-16-one
  • (17E)-4,4,14-Trimethyl-3β-(methylamino)-9β,19-cyclo-5α-pregn-17(20)-en-16-one
  • Buxenone M
  • Cyclobuxophyllinine
  • Cyclobuxophyllinine M
  • 9,19-Cyclopregn-17(20)-en-16-one, 4,4,14-trimethyl-3-(methylamino)-, (3β,5α,17E)-
  • 1053-21-0
Copyright 2019 © ChemicalBook. All rights reserved